| Serial Number | 79402309 |
| Word Mark | SEAMLESS |
| Filing Date | Thursday, December 14, 2023 |
| Status | 760 - EX PARTE APPEAL PENDING |
| Status Date | Monday, November 10, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Chemicals for use in industry and science; biological preparations and biological chemical reagents for use in industry and science; all of the foregoing used for non-medical purposes |
| Description of Mark | The mark consists of the wording "SEAMLESS" in stylized font next to the letter "S" comprised of curved bands. |
| Goods and Services | Scientific and technological services, namely, product research and testing of pharmaceuticals for cell and gene therapies in the field of pharmaceutical product development for the creation of bioinformatic algorithms and models; development of pharmaceutical preparations and medicines, none of the foregoing for diagnostics; pharmaceutical product development, none of the foregoing for diagnostics; pharmaceutical products development of genome editable enzymes for treatment and not diagnostic purposes; pharmaceutical products development of DNA editable enzymes, in particular recombinases and integrases, for treatment and not diagnostic purposes |
| Goods and Services | Pharmaceutical and biological preparations for gene therapies and gene-editing therapies, all for the treatment of genetic and viral diseases; medical, pharmaceutical and biopharmaceutical preparations and substances containing programmable recombinases for the treatment of genetic and viral diseases; pharmaceutical goods and preparations, namely, gene transfer, regulation, modulation and delivery medications for the treatment of genetic and viral diseases and disorders; products, agents, for medical purposes, for veterinary purposes in the nature of pharmaceutical preparations for cellular, genome and gene editing therapies to treat genetic, oncological, immune system-related, and inflammatory disorders and diseases; genome editable enzymes being enzymes for medical purposes; DNA recombinant enzymes being enzymes for medical purposes; DNA editable enzymes, especially, recombinases and integrases being enzymes for medical purposes; genome editable enzymes for the treatment of diseases being enzymes for medical purposes; DNA recombinant enzymes for the treatment of diseases being enzymes for medical purposes; DNA editable enzymes, in particular recombinases and integrases, for the treatment of diseases being enzymes for medical purposes; DNA editable enzymes, especially, recombinases and integrases being enzymes for medical purposes; genome editable enzymes for the treatment of diseases being enzymes for medical purposes; DNA recombinant enzymes for the treatment of diseases being enzymes for medical purposes; DNA editable enzymes, in particular recombinases and integrases, for the treatment of diseases being enzymes for medical purposes |
| Goods and Services | Medical services provided to pharmaceutical companies in the field of gene sequencing, gene editing and gene sequencing technologies; Medical analysis services relating to the treatment of patients provided to pharmaceutical companies in the field of gene sequencing, gene editing and gene sequencing technologies; Medical information services relating to the treatment of patients provided to pharmaceutical companies regarding gene therapies and gene editing therapies; genetic counseling regarding gene therapies and gene editing relating to the treatment of patients, provided to pharmaceutical companies |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 15, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 15, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 15, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 15, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Seamless Therapeutics GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | DE |
| Event Date | Event Description |
| Thursday, August 15, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Wednesday, August 21, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, August 21, 2024 | APPLICATION FILING RECEIPT MAILED |
| Thursday, August 22, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, September 3, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, September 4, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Saturday, September 7, 2024 | REFUSAL PROCESSED BY MPU |
| Saturday, September 7, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, September 30, 2024 | REFUSAL PROCESSED BY IB |
| Friday, March 7, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, March 7, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, March 7, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, April 19, 2025 | FINAL REFUSAL WRITTEN |
| Saturday, April 19, 2025 | FINAL REFUSAL E-MAILED |
| Saturday, April 19, 2025 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Monday, October 20, 2025 | EXPARTE APPEAL RECEIVED AT TTAB |
| Monday, October 20, 2025 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| Monday, October 20, 2025 | EX PARTE APPEAL-INSTITUTED |
| Monday, October 20, 2025 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Monday, October 27, 2025 | ASSIGNED TO LIE |
| Monday, October 27, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, October 27, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, November 10, 2025 | ACTION CONTINUING FINAL - COMPLETED |
| Monday, November 10, 2025 | ACTION DENYING REQ FOR RECON E-MAILED |
| Monday, November 10, 2025 | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED |